NASDAQ:ZYBT | Free Cash Flow | Zhengye Biotechnology Holding Ltd

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2024-12-31 to 2025-12-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$1.91M$144,000.00$1.77M
2024-12-31$5.62M$1.86M$3.76M242.71%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.